We are live on ! Find out more
FC

Finepoint Capital Portfolio holdings

AUM $1.95B
1-Year Est. Return 45.61%
This Fund
S&P 500
This Quarter Est. Return
+40.23%
1 Year Est. Return
+45.61%
3 Year Est. Return
+24.83%
5 Year Est. Return
+26.66%
10 Year Est. Return
–
AUM
$317M
AUM Growth
+$116M
Cap. Flow
+$77.4M
Cap. Flow %
24.42%
Top 10 Hldgs %
71.68%
Holding
32
New
2
Increased
6
Reduced
1
Closed
5

Top Buys

Rank Stock Value
1
MLTX icon
MoonLake Immunotherapeutics
MLTX
+$29M
2
LBRDK icon
Liberty Broadband Class C
LBRDK
+$15.5M
3
ACAD icon
Acadia Pharmaceuticals
ACAD
+$5.09M
4
RVMD icon
Revolution Medicines
RVMD
+$4.57M
5
MORF
Morphic Holding, Inc. Common Stock
MORF
+$4.08M

Top Sells

Rank Stock Value
1
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$12.3M
2
AAC.WS
Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AAC.WS
+$334K
3
BTWNW
Bridgetown Holdings Limited Warrants
BTWNW
+$304K
4
CCVI.WS
Churchill Capital Corp VI Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
CCVI.WS
+$86.4K
5
HPLTW
Home Plate Acquisition Corporation Warrant
HPLTW
+$1.97K

Sector Composition

Rank Sector Weight
1 Healthcare 80.12%
2 Communication Services 4.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IVCPW
26
DELISTED
Swiftmerge Acquisition Corp. Warrants
IVCPW
$20.1K 0.01%
490,000
– –
LSBPW
27
DELISTED
LakeShore Biopharma Warrants
LSBPW
$13.3K ﹤0.01%
489,999
– –
CERE
28
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
– –
-563,345
Closed -$12.3M
CCVI.WS
29
DELISTED
Churchill Capital Corp VI Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
CCVI.WS
– –
-540,000
Closed -$86.4K
AAC.WS
30
DELISTED
Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AAC.WS
– –
-504,706
Closed -$334K
CCV.WS
31
DELISTED
Churchill Capital Corp V Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
CCV.WS
– –
-612,000
Closed –
BTWNW
32
DELISTED
Bridgetown Holdings Limited Warrants
BTWNW
– –
-895,000
Closed -$304K
1
2

Similar funds

NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
WPC
Waters Parkerson & Co New Orleans, Louisiana $1.95B AUM 15.9% 1-Year Est. Return
SGAM
Smith Group Asset Management Dallas, Texas $1.96B AUM 43.61% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
BC
Blackhill Capital Morristown, New Jersey $1.94B AUM 18.09% 1-Year Est. Return
FFH
Fairfax Financial Holdings Toronto, Ontario, Canada $1.94B AUM 27.76% 1-Year Est. Return
NFG
Nations Financial Group Cedar Rapids, Iowa $1.94B AUM 25.76% 1-Year Est. Return
MWA
Midland Wealth Advisors Effingham, Illinois $1.94B AUM 14.31% 1-Year Est. Return

Finepoint Capital's Q4 2023 Portfolio in Review

As of Q4 2023, Finepoint Capital held 32 positions worth $317M, up 58% from $201M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Finepoint Capital deployed $77.4M of net new capital in Q4 2023, opening 2 new positions and adding to 6 existing holdings. Its largest new stake was Liberty Broadband Class C: 184,460 shares worth $14.9M.

By sector, the portfolio is most concentrated in Healthcare at 80% of assets, down from 99% a quarter earlier, followed by Communication Services.

On the sell side, the largest reduction was Home Plate Acquisition Corporation Warrant, an estimated $1.97K trimmed.

  • Finepoint Capital's largest Q4 2023 buy was Liberty Broadband Class C: 184,460 shares worth $14.9M.
  • Finepoint Capital added most to MoonLake Immunotherapeutics in Q4 2023, an estimated $29M increase.
  • Finepoint Capital's biggest Q4 2023 reduction was Home Plate Acquisition Corporation Warrant, cutting an estimated $1.97K.
  • Finepoint Capital fully exited Cerevel Therapeutics Holdings, Inc. Common Stock in Q4 2023, selling an estimated $12.3M.
  • Finepoint Capital's ten largest holdings make up 72% of its $317M portfolio in Q4 2023.
  • Finepoint Capital opened 2 new positions and closed 5 in Q4 2023.
  • Finepoint Capital's portfolio value rose 58% quarter-over-quarter to $317M.

Based on Finepoint Capital's 13F filing for Q4 2023, filed 13 Feb 2024.